References
- Adams, J.M. and Cory, S., 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 26(9), 1324–1337.
- Akhdar, H., et al., 2012. Anticancer drug metabolism: chemotherapy resistance and new therapeutic approaches. In: James Paxton, ed. Topics on drug metabolism. Croatia: InTech, 137–173.
- Antić, V., 2014. Colorectal cancer incidence variation in Serbian districts. Medical journal (Kragujevac), 48(1), 48–53.
- Baguley, B., 2010. Multiple drug resistance mechanisms in cancer. Molecular biotechnology, 46(3), 308–316.
- Bakos, E., et al., 2000. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Molecular pharmacology, 57(4), 760–768.
- Baskić, D., et al., 2006. Analysis of cyclohexamide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell biology international, 30(11), 924–932.
- Bogdanov, S., 2017. Propolis: composition, health, medicine: a review. Bee Product Science. Available from: www.bee-hexagon.net
- Chomczynski, P. and Sacchi, N., 1987. Single-step method of RNА isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical biochemistry, 162(1), 156–159.
- Dinić, J., et al., 2015. New approaches with natural product drugs for overcoming multidrug resistance in cancer. Current pharmaceutical design, 21(38), 5589–5604.
- Evers, R., et al., 2000. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. British journal of cancer, 83(3), 366–374.
- Gajski, G. and Garaj-Vrhovac, V., 2013. Melittin: a lytic peptide with anticancer properties. Environmental toxicology and pharmacology, 36(2), 697–705.
- Gomes, A., et al., 2010. Anticancer potential of animal venoms and toxins. Indian journal of experimental biology, 48(2), 93–103.
- Guanti, G., et al., 2000. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Human molecular genetics, 9(2), 283–287.
- Guengerich, F.P., 2007. Cytochrome P450 and chemical toxicology. Chemical research in toxicology, 21(1), 70–83.
- Higuchi, H., et al., 2001. The bile acid glycochenodeoxycholate induces TRAIL-Receptor 2/DR5 expression and apoptosis. Journal of biological chemistry, 276(42), 38610–38618.
- Ip, S.W., et al., 2008. The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7. In vivo (Athens, Greece), 22(2), 237–246.
- Jo, M., et al., 2012. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and applied pharmacology, 258(1), 72–81.
- Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680–685.
- Lee, H.L., et al., 2015. Bee venom inhibits growth of human cervical tumors in mice. Oncotarget, 6(9), 7280–7292.
- Mayer, B. and Oberbauer, R., 2003. Mitochondrial regulation of apoptosis. Physiology, 18(3), 89–94.
- Milutinović, M., et al., 2015. The molecular mechanisms of apoptosis induced by Allium flavum L. and synergistic effects with new-synthesized Pd(II) complex on colon cancer cells. Journal of food biochemistry, 39(3), 238–250.
- Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods, 65(1–2), 55–63.
- Ozoren, N. and El-Deiry, W.S., 2002. Defining characteristics of types I and II apoptotic cells. Neoplasia, 4(6), 551–557.
- Premratanachai, P. and Chanchao, C., 2014. Review of the anticancer activities of bee products. Asian Pacific Journal of Tropical Biomedicine, 4(5), 337–344.
- Schmittgen, T.D. and Livak, K.J., 2008. Analyzing real-time PCR data by the comparative C(T) method. Nature protocols, 3(6), 1101–1108.
- Son, D.J., et al., 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology and therapeutics, 115, 246–270.
- Torre, L.A., et al., 2015. Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65(2), 87–108.
- Zheng, J., et al., 2015. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget, 6(42), 44437–44451.